United Therapeutics reports second quarter 2014 financial results
United Therapeutics reported total revenues for the 2014 second quarter were $322.8 million, up from $280.6 million for the same 2013 quarter. Net income for the 2014 quarter was $111.9 million or $2.35 per basic share, versus $79.9 million or $1.60 per basic share for the same quarter in 2013. July 29, 2014